Reuters logo
10 months ago
BRIEF-Cadila Healthcare says Zydus signs deal with MMV to develop potential antimalarial drug
September 30, 2016 / 4:30 AM / 10 months ago

BRIEF-Cadila Healthcare says Zydus signs deal with MMV to develop potential antimalarial drug

1 Min Read

Sept 30 (Reuters) - Cadila Healthcare Ltd:

* Zydus and Medicines for Malaria Venture sign agreement to develop potential new antimalarial drug

* Zydus will lead development of novel compound and MMV will provide support Source text: bit.ly/2dr6283 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below